Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01406119 · ClinicalTrials.gov registry record · Phase 1
An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors
A Phase 1 study, sponsored by AbbVie (prior sponsor, Abbott).
- Completed
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT01406119 is a Phase 1 study that has completed, run by AbbVie (prior sponsor, Abbott). The registered enrollment target is 14 participants.
The verdict
NCT01406119, a Phase 1 study, has completed, sponsored by AbbVie (prior sponsor, Abbott).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
This is an extension study of ABT-806 for subjects with advanced solid tumors.
Interventions
- DRUG ABT-806
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2011-10 |
| Est. Completion | 2017-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01406119
The ClinicalTrials.gov registry entry for NCT01406119 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AbbVie (prior sponsor, Abbott), which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ABT-806 is the first listed.
NCT01406119 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01406119 about?
NCT01406119 is a clinical study titled "An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors". This is an extension study of ABT-806 for subjects with advanced solid tumors.
What is the current status of trial NCT01406119?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2011-10. Estimated completion is 2017-01.
What interventions are being tested in trial NCT01406119?
The interventions under investigation include: ABT-806 (DRUG).
Who is sponsoring clinical trial NCT01406119?
This trial is sponsored by AbbVie (prior sponsor, Abbott), which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.